HNI Commodity Pack, Jubilant Life gains 1%, to acquire radiopharmacy biz of Triad Isotopes

Shares of Jubilant Life Sciences gained 1.6 percent intraday Friday as it is going to acquire the radiopharmacy business of Triad Isotopes.

"Jubilant Pharma, a material wholly owned subsidiary of Jubilant Life Sciences, through one of its wholly-owned subsidiaries, has signed an asset purchase agreement with Triad Isotopes Inc. and its parent, Isotope Holdings, Inc. to acquire substantially all of the assets which comprise the radiopharmacy business of Triad," as per company release.

"The closing of the transaction is subject to customary closing conditions, including contract, regulatory and other approvals. The sails acquisition will be funded through Jubilant Pharma’s internal accruals," it added.

Most valuable #Financial Advisory with the name of accurate tips provider here invites you to trade in a financial market with a risk-free work click here for more >> http://www.ripplesadvisory.com